Power Up Your Brain
Power Up Your Brain
by David Perlmutter, MD, FACN, ABIHM &
Albert Villoldo, Ph.D
Raise a Smarter Child by Kindergarten
Raise a Smarter Child by Kindergarten
by David Perlmutter, MD, FACN, ABIHM
The Better Brain Book


by David Perlmutter, MD, FACN, ABIHM
Read Dr. Perlmutter's
articles at

AP Poll: Third of parents oppose swine flu vaccine

October 10th, 2009

From WashingtonPost.com:

As the first wave of swine flu vaccine crosses the country, more than a third of parents don’t want their kids vaccinated, according to an Associated Press-GfK poll.

Some parents say they are concerned about side effects from the new vaccine – even though nothing serious has turned up in tests so far – while others say swine flu doesn’t amount to any greater health threat than seasonal flu.

Jackie Shea of Newtown, Conn., the mother of a 5-year-old boy named Emmett, says the vaccine is too new and too untested.

“I will not be first in line in October to get him vaccinated,” she said in an interview last month. “We’re talking about putting an unknown into him. I can’t do that.”

The AP poll found that 38 percent of parents said they were unlikely to give permission for their kids to be vaccinated at school.

The belief that the new vaccine could be risky is one federal health officials have been fighting from the start, and they plan an unprecedented system of monitoring for side effects.

They note that swine flu vaccine is made the same way as seasonal flu vaccines that have been used for years. And no scary side effects have turned up in tests on volunteers, including children.

On Wednesday, Health and Human Services Secretary Kathleen Sebelius appealed for widespread inoculation against swine flu, vouching unconditionally for the vaccine: “We know it’s safe and secure.”

The AP poll, conducted Oct. 1-5, found 72 percent of those surveyed are worried about side effects, although more than half say that wouldn’t stop them from getting the vaccine to protect their kids from the new flu.

Giving flu shots to schoolchildren is also an idea many parents are still getting used to. It was only last year that the government recommendation kicked in for virtually all children to get it. Seasonal flu vaccination rates for children last year ranged from about 48 percent for toddlers to about 9 percent for teens.

It traditionally takes a while for parents to learn about and accept a new vaccine and years for immunization rates to grow, said Dr. Matthew Davis, a University of Michigan Medical School associate professor who has overseen polling on flu issues.

Special swine flu vaccination clinics at schools are being planned in many states. Children are the main spreaders of infectious disease, and if large numbers are coming down with swine flu, there are ripple effects for everyone else.

Preparing for the Swine Flu

September 3rd, 2009

From NYTimes.com:

There was a lot of confusion last week about swine flu. A presidential advisory group issued a “plausible scenario” in which a swine flu epidemic could cause up to 90,000 deaths, three times the mortality in a typical flu season. The Centers for Disease Control and Prevention countered that the toll would most likely not approach that number.

Our own take is this: A swine flu epidemic this fall and winter is likely to infect more people than a normal flu, but the virus will not be abnormally lethal. If it spreads rapidly after schools open, we will have to face it without vaccine, which will not arrive in substantial quantities until the swine flu epidemic has peaked.

The report that sparked concern was issued by the President’s Council of Advisors on Science and Technology. The council stressed that it was not predicting what would happen but was simply offering a scenario to help the government develop responses to a potential epidemic.

The report posited an epidemic that could produce symptoms in 60 million to 120 million people and cause as many as 90 million to seek medical attention; up to 1.8 million could be hospitalized, 300,000 could flood into crowded I.C.U.’s, and 30,000 to 90,000 people could die.

Even some members of the advisory panel think their estimates may be a bit high. In any case, this is a virus that is no more lethal, and possibly less lethal, than normal flu strains.

In the initial outbreaks last spring, an estimated 800,000 New Yorkers, 10 percent of the city’s population, developed symptoms attributed to the swine flu virus. Only 54 died — an encouragingly low death rate. Most infected people got better without medical treatment.

Another encouraging sign is that the virus has not become more virulent as it wends its way around the world. Finally, the United States is better prepared than ever before. The Bush administration and Congress invested heavily in planning and in stockpiling medicines and medical supplies to fight a feared avian flu pandemic that never materialized, and the Obama administration has continued the effort. The same medicines should work against the swine flu virus.

The rub is that a vaccine to prevent swine flu is still being tested and will not be ready until mid-October, too late to help most people if the virus spreads rapidly in September after schools and colleges open almost everywhere. The standard advice will be to cover our coughs, wash our hands, and stay home if sick. There will be medicines to treat the very sick.

The swine flu virus seems to infect mostly people under age 65, in contrast with seasonal flus that primarily harm the elderly. Health officials are assuming that they have to prepare for both kinds of flu to be circulating and will be offering vaccines to protect against both. Whatever damage swine flu causes may well be piled on top of the normal flu sickness and deaths.

Do viruses make bacteria more deadly?

June 25th, 2009

From news-medical.net:

In England and Wales, the national health statistics in 2007 showed that there were 8,324 death certificates which named Clostridium difficile. This is a bacterium which causes severe diarrhoea in humans and animals as the underlying cause of death, a 28% increase from 2006.

Now Janet Nale of the Department of Infection, Immunity and Inflammation is investigating the contributing factors that make Clostridium difficile so aggressive to direct treatment.

She will be presenting her research at the Festival of Postgraduate Research which is taking place on Thursday 25th June in the Belvoir Suite, Charles Wilson Building at the University of Leicester between 11:30am and 1pm. This event is open to the public and is free to attend.

Nale said: “Bacteriophages are viruses that infect bacteria and some can completely change the behaviour of their host bacteria, or affect its ability to cause disease. In some cases, bacteriophages have been shown to convert a mild strain to a severe one.

“My project seeks to understand the contribution viruses make to the level of infection caused by C. difficile R027. My current research will investigate bacteriophages from 91 strains of Clostridium difficile R027 isolated from 9 hospitals in England and Wales.

“These insights should help us to understand one of the main factors that contributes to making C. difficile so aggressive and this can direct treatment.”

USA ill-equipped for a swine flu pandemic, experts fear

May 15th, 2009

From USAToday.com:
Though health officials say the swine flu outbreak appears relatively mild, some medical experts say the USA is unprepared in many ways to handle a severe pandemic.
States, cities and public health agencies have made enormous progress in preparing for health crises such as bioterrorism and a flu pandemic since the anthrax attacks in 2001, says Neal Cohen of Hunter College’s School of Urban Public Health, who was New York City’s health commissioner from 1998 to 2002.
More recent threats, such as SARS in 2003, have given doctors and nurses a “dress rehearsal” for a pandemic, Cohen says, allowing them to test strategies for dealing with dangerous new viruses.

The world is “better prepared for an influenza pandemic than at any time in history,” said Margaret Chan, director general of the World Health Organization, last week.

Yet even before the flu outbreak, emergency rooms could barely handle all the patients coming through their doors, says Katherine Heilpern, chair of Emory University’s Department of Emergency Medicine in Atlanta. “Most emergency rooms are working at or above capacity,” she says.

Equipment in limited supply

Hundreds of ERs have shut down over the past 15 years, largely because of financial pressures, including declining reimbursements from insurance programs such as Medicare, Heilpern says.

But the number of emergency room patients grew 32% from 1996 to 2006, according to the American College of Emergency Physicians. Emergency rooms have little “surge capacity,” the ability to gear up to treat many more patients, Heilpern says.

Even hospital equipment could be in short supply. In a pandemic, hospitals might not have enough mechanical ventilators — used when patients have severe trouble breathing, Heilpern says.

Up to 80,000 of the nation’s 105,000 ventilators are being used for everyday medical care, and nearly all of them are used during a normal flu season, according to a 2007 editorial in The New England Journal of Medicine.

Even if hospitals were able to order more machines, many hospitals don’t have enough critical care nurses, respiratory therapists or intensive care doctors to open up more beds in their intensive care units, Heilpern says.

In a pandemic, doctors could be forced to ration ventilators, using them on patients who have the most to gain, such as those who — though severely ill in the short term — are otherwise healthy enough to recover, she says.

In a crisis, Heilpern says, hospital beds might be reserved for the sickest patients; others would be treated at outpatient clinics.

Health workers also might have to set up triage centers in public places, such as parking lots, to decide which patients are well enough to recuperate at home and which need medical attention. At Emory, Heilpern has even raised the idea of “drive-through” flu triage, with health workers performing quick assessments of heart rate, breathing and mental status through the window.

And pandemics can be like marathons, according to an article published last week in The New England Journal of Medicine, which notes that they can continue taking lives for two to five years.

Will vaccines, antivirals work?

Other experts say the world could have trouble manufacturing enough vaccine.

Because viruses can change rapidly, a vaccine produced today might not match the viral strain circulating next winter, Cohen says. The Centers for Disease Control and Prevention has not yet decided whether to make a vaccine for H1N1, a manufacturing process that could take months.

The World Health Organization has said manufacturers could produce 1 billion to 2 billion doses. That’s enough to protect 17% to 33% of the population with one dose. If it takes two doses to produce that immunity, only half as many would be protected.

“Clearly, we need a major initiative in the vaccine area,” says Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota.

In the USA, health professionals, emergency workers and people at high risk for complications, such as babies and pregnant women, would be vaccinated first, according to the national vaccine plan.

Osterholm commends the federal government for building a robust stockpile of antiviral drugs. Between national, state and military supplies, the nation can treat 80 million people, or about 25% of the population, with antivirals, which can lessen the flu’s severity if given within 48 hours of the appearance of symptoms and even prevent the flu if given to household members of flu patients.

Considering that influenza often has an “attack rate” of 25% to 40%, those supplies may be enough, Osterholm says. But in a very severe outbreak, a person might need four times the usual amount of Tamiflu, leaving enough drugs for about 6% of the population, says John Bartlett, a professor in infectious diseases at Johns Hopkins University School of Medicine.

Antiviral medications might not work at all if the flu virus becomes resistant to it, Bartlett says. A strain of seasonal flu that caused about 45% of the infections this past winter was resistant to Tamiflu, he says. That resistance developed very quickly. Two years ago, only 1% of that flu virus strain was resistant. Now, 99% of that strain is resistant, Bartlett says.

FDA moves against swine flu fraud

May 7th, 2009

From The Associated Press:

The Food and Drug Administration has found at least 20 Web sites that may be fraudulently marketing products with claims that they guard against or cure swine flu, an agency official said Monday.

The FDA publicly rebuked one such site Monday — http://rebuildermedical.com — for offering a $199 “SilverCure Swine Flu Protection Pack” that includes shampoo, lotion, conditioner and soap that supposedly deposit traces of silver.

“Everything you need to protect yourself and family,” the Web site says. But the FDA says no silver-based products have been approved for swine flu treatment or prevention, so it’s illegal to claim such benefits.

Alyson Saben, who heads a new FDA swine flu consumer fraud team, told The Associated Press in an interview that ReBuilderMedical Technologies Inc. will have 48 hours to take corrective action or face criminal or regulatory action from the FDA.

A phone message and e-mail to the company were not immediately returned.

Officials on the new swine fraud team working over the weekend found at least 20 other sites peddling products for swine flu accompanied by potentially fraudulent claims, Saben said.

She declined to identify the other sites until the agency investigates their claims and makes a decision about their accuracy. But she said they were things like antiviral medications being sold without a doctor’s prescription, dietary supplements with exaggerated claims, and flu diagnostic and protection kits.

“Unfortunately we see that these deceptive products are being offered, and by purveyors of products that take advantage of the public’s concerns about the virus,” Saben said. “FDA will consider whatever means are necessary and available to us to immediately stop the marketing of unapproved, uncleared or unauthorized products.”

The FDA is asking members of the public to notify the agency when they encounter potentially fraudulent products. Tips can be submitted at: http://www.fda.gov/oci/flucontact.html

Forms of silver like ionic silver or colloidal silver — none of them approved for swine flu — are nonetheless easy to find online accompanied by claims that they fight or prevent the new flu. A Web site called http://www.swineflugone.com is selling a 2 oz. spritzer bottle with a concoction of ionic silver, echinecea, eucalyptus and spearmint and claiming it will “Stop Swine Flu in Its Tracks.”

Another site, http://www.flu-watch.org, claims to disclose “What the CDC won’t tell you that just may save your life.” Colloidal silver is offered as a lifesaving cure.

Other sites are selling the antiviral Tamiflu apparently without requiring a doctors’ prescriptions, or expensive kits of surgical masks, gloves, and anti-bacterial wipes and gels.

Surgical masks and gloves are medical devices and must have FDA approval. But even if the items themselves being sold are FDA-approved, the claims being made about them may not be accurate, Saben said.

The Centers for Disease Control and Prevention does not recommend widespread use of face masks, saying only that they may be useful — along with other measures — for people who may be in close contact with people may have flu. Surgical gloves are only recommended for people like first responders having direct contact with ill people.

FDA swine flu fraud page